Recurring concern
Unreliable biopsy documentation and reporting
- Reports that mention this concern
- 2
- Times this concern has been raised
- 2
- Stated actions linked to this concern
- 1
What this concern includes
Includes failures in biopsy documentation and reporting controls, including sufficient report capacity, documented addenda, recording of procedures and outcomes, traceability, retrieval and related quality-assurance arrangements for biopsy records.
What is not included
- Excludes clinical decisions about whether to perform a biopsy when the documentation and reporting process is not deficient.
- Excludes delays in obtaining or performing biopsies where no biopsy documentation or reporting failure is identified.
- Excludes laboratory processing, histopathology interpretation or treatment failures after biopsy information has been reliably documented and made available.
- Excludes generic clinical-record deficiencies unrelated to biopsy procedures, findings, reports or outcomes.
Trends
Reports over time
Reports mentioning this concern, over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Reports and published responses 2 reports
See individual reports that have raised this concern, and the actions taken in response
-
Concerns raised1
Lack of a database to record Bone Marrow Aspirate and trephine biopsy procedures and outcomes
This report raised 1 other concern. They are not shown here because they do not form part of this recurring concern.
Linked responses
- British Society for Haematology
- NHS England
Stated actions An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.1
-
British Society for Haematology
Explore developing a registry of complications to inform future guidance.
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.2
-
NHS England
NHS England does not consider developing a registry for bone marrow aspiration and trephine biopsy necessary at this point.
-
NHS England
The British Society for Haematology, as the responsible professional society, is undertaking relevant guidance and procedure-safety work.
-
Concerns raised1
Inadequate space or lack of addendum provision in biopsy reporting forms
No linked response statementsNo respondent-stated action or position is linked to these concerns in the published data.
Actions and positions describe what organisations say in published responses. Implementation is not independently verified.
Data last updated 7 September 2026